Abstract
Facioscapulohumeral muscular dystrophy (FSHD) is the third most common neuromuscular disorder after Duchenne muscular dystrophy and myotonic dystrophy (Upadhyaya and Cooper 2002). It is characterized by progressive weakness and atrophy of the facial and shoulder girdle muscles. The other muscles are also involved. Its prevalence is estimated to be 1 in 20,000 in Europe (Lunt and Harper 1991).
This is a preview of subscription content, log in via an institution.
References
Bakker, E., Van der Wielen, M. J., Voorhoeve, E., et al. (1996). Diagnostic, predictive, and prenatal testing for facioscapulohumeral muscular dystrophy: Diagnostic approach for sporadic and familial cases. Journal of Medical Genetics, 33, 29–35.
Ciafaloni, E., Pressman, E. K., Lori, A. M., et al. (2006). Pregnancy and birth outcomes in women with facioscapulohumeral muscular dystrophy. Neurology, 67, 1887–1889.
Eger, K., Jordan, B., Habermann, S., et al. (2010). Beevor’s sign in facioscapulohumeral muscular dystrophy: An old sign with new implications. Journal of Neurology, 257, 436–438.
Eggers, S., Passos-Bueno, M. R., & Zatz, M. (1993). Facioscapulohumeral muscular dystrophy: Aspects of genetic counselling, acceptance of preclinical diagnosis, and fitness. Journal of Medical Genetics, 30, 589–592.
Felice, K. J., & Moore, S. A. (2001). Unusual clinical presentations in patients harboring the facioscapulohumeral dystrophy 4q35 deletion. Muscle & Nerve, 24, 352–356.
Fitzsimons, R. B. (1999). Facioscapulohumeral muscular dystrophy. Current Opinion in Neurology, 12, 501–511.
Kissel, J. T. (1999). Facioscapulohumeral dystrophy. Seminars in Neurology, 19, 35–43.
Köhler, J., Rupilius, B., Otto, M., et al. (1996). Germline mosaicism in 4q35 facioscapulohumeral muscular dystrophy (FSHD1A) occurring predominantly in oogenesis. Human Genetics, 98, 485–490.
Laforet, P., de Toma, C., Eymard, B., et al. (1998). Cardiac involvement in genetically confirmed facioscapulohumeral muscular dystrophy. Neurology, 51, 1454–1456.
Lemmers, R.J.L.F., & van der Maarel, S.M. (2014). Facioscapulohumeral muscular dystrophy. GeneReviews. Updated 20 Mar 2014. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1443/
Lemmers, R. J., Wohlgemuth, M., van der Gaag, K. J., et al. (2007). Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy. American Journal of Human Genetics, 81, 884–894.
Lunt, P. W., & Harper, P. S. (1991). Genetic counseling in facioscapulohumeral muscular dystrophy. Journal of Medical Genetics, 28, 655–664.
Lunt, P. W., Jardine, P. E., Koch, M., et al. (1995). Phenotypic-genotypic correlation will assist genetic counseling in 4q35-facioscapulohumeral muscular dystrophy. Muscle & Nerve, 2, S103–S109.
Orrell, R. W., Tawil, R., Forrester, J., et al. (1999). Definitive molecular diagnosis of facioscapulohumeral dystrophy. Neurology, 52, 1822–1826.
Padberg, G. W., & van Engelen, B. G. M. (2009). Facioscapulohumeral muscular dystrophy. Current Opinion in Neurology, 22, 539–542.
Ricci, E., Galluzzi, G., Deidda, G., et al. (1999). Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q25 locus and clinical phenotype. Annals of Neurology, 45, 751–757.
Rudnik-Schoneborn, S., Glauner, B., Rohrig, D., et al. (1997). Obstetric aspects in women with facioscapulohumeral muscular dystrophy, limb-girdle muscular dystrophy, and congenital myopathies. Archives of Neurology, 54, 888–894.
Sacconi, S., Lemmers, R. J. L. F., Balog, J., et al. (2013). The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1. American Journal of Human Genetics, 93, 744–751.
Sacconi, S., Salviati, L., & Desnuelle, C. (2015). Facioscapulohumeral dystrophy. Biochimica et Biophysica Acta, 1852, 607–614.
Sripathi, N. (2014). Facioscapulohumeral dystrophy. eMedicine from WebMD. Updated 16 Oct 2014. Available at: http://emedicine.medscape.com/article/1176126-overview
Statland, J., & Tawil, R. (2014). Facioscapulohumeral dystrophy. Neurologic Clinics, 32, 721–728.
Statland, J., Donlin-smith, C. M., Tapscott, S. J., et al. (2014). Multiplex screen of serum biomarkers in Facioscapulohumeral dystrophy. Journal of Neuromuscular Disorders, 1, 181–190.
Tawil, R., & Van Der Maarel, S. M. (2006). Facioscapulohumeral muscular dystrophy. Muscle & Nerve, 34, 1–15.
Tawil, R., Forrester, J., Griggs, R. C., et al. (1996). Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group. Annals of Neurology, 39, 744–748.
Tawil, R., Figlewicz, D. A., Griggs, R. C., et al. (1998). Facioscapulohumeral dystrophy: A distinct regional myopathy with a novel molecular pathogenesis. FSH consortium. Annals of Neurology, 43, 279–282.
Tawil, R., van der Maarel, S., Padberg, G. W., et al. (2010). 171st ENMC International Workshop: Standards of care and management of facioscapulohumeral muscular dystrophy. Neuromuscular Disorders, 20, 471–475.
Tawil, R., Kissel, J. T., Heatwole, C., et al. (2015). Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy. Neurology, 85, 357–364.
Upadhyaya, M., & Cooper, D. N. (2002). Molecular diagnosis of facioscapulohumeral muscular dystrophy. Expert Review of Molecular Diagnostics, 2, 160–171.
Upadhyaya, M., Maynard, J., Osborn, M., et al. (1995). Germinal mosaicism in facioscapulohumeral muscular dystrophy (FSHD). Muscle & Nerve, 2, S45–S49.
Upadhyaya, M., MacDonald, M., & Ravine, D. (1999). Prenatal diagnosis for facioscapulohumeral muscular dystrophy (FSHD). Prenatal Diagnosis, 19, 959–965.
van Deutekom, J. C., Bakker, E., Lemmers, R. J., et al. (1996). Evidence for subtelomeric exchange of 3.3 kb tandemly repeated units between chromosomes 4q35 and 10q26: Implications for genetic counselling and etiology of FSHD1. Human Molecular Genetics, 5, 1997–2003.
Wohlgemuth, M., van der Kooi, E. L., van Kesteren, R. G., et al. (2004). Ventilatory support in facioscapulohumeral muscular dystrophy. Neurology, 63, 176–178.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this entry
Cite this entry
Chen, H. (2017). Facioscapulohumeral Muscular Dystrophy. In: Atlas of Genetic Diagnosis and Counseling. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2401-1_84
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2401-1_84
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2400-4
Online ISBN: 978-1-4939-2401-1
eBook Packages: MedicineReference Module Medicine